{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:20:57Z","timestamp":1761168057931,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD061879","DK054481","DK66448","RR02512"],"award-info":[{"award-number":["HD061879","DK054481","DK66448","RR02512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ymgme.2014.12.305","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T03:10:18Z","timestamp":1419045018000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The effect of Tlr4 and\/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice"],"prefix":"10.1016","volume":"114","author":[{"given":"Elizabeth M.","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine P.","family":"Ponder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2014.12.305_bb0005","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","article-title":"Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis","volume":"82","author":"Sly","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(75)80968-1","article-title":"Variation in the phenotypic expression of beta-glucuronidase deficiency","volume":"86","author":"Beaudet","year":"1975","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0020","first-page":"132","article-title":"Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency","volume":"7","author":"Vogler","year":"1994","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajmg.1320440206","article-title":"Mucopolysaccharidosis type VII (beta-glucuronidase deficiency): a chronic variant with an oligosymptomatic severe skeletal dysplasia","volume":"44","author":"de Kremer","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2012.03.014","article-title":"Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII","volume":"107","author":"Smith","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0035","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1073\/pnas.192353499","article-title":"Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs","volume":"99","author":"Ponder","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2008.07.003","article-title":"Radiographic evaluation of bones and joints in mucopolysaccharidosis I and VII dogs after neonatal gene therapy","volume":"95","author":"Herati","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2013.03.013","article-title":"The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade","volume":"109","author":"Xing","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","article-title":"Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs","volume":"82","author":"Mango","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002296","article-title":"Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice","volume":"3","author":"Ausseil","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0070","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022447","article-title":"Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis Type VI","volume":"6","author":"Eliyahu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0080","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100882","article-title":"Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment","volume":"9","author":"Frohbergh","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054459","article-title":"Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses","volume":"8","author":"Schuchman","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11926-013-0350-2","article-title":"Genetically engineered mouse models reveal the importance of proteases as osteoarthritis drug targets","volume":"15","author":"Miller","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00281-003-0125-3","article-title":"The TNF-alpha transgenic mouse model of inflammatory arthritis","volume":"25","author":"Li","year":"2003","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.molcel.2007.06.038","article-title":"Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation","volume":"27","author":"Lim","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1744-313X.2010.00920.x","article-title":"Genome-wide haplotype association analysis and gene prioritization identify CCL3 as a risk locus for rheumatoid arthritis","volume":"37","author":"Zhang","year":"2010","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/imt.14.26","article-title":"Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects","volume":"6","author":"Garc\u00eda-Hern\u00e1ndez","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0809","article-title":"Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy","volume":"6","author":"Xu L","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/BPO.0000000000000168","article-title":"Musculoskeletal function in patients with mucopolysaccharidosis using the pediatric outcomes data collection instrument","volume":"34","author":"O'Brien","year":"2014","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0135","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ymgme.2011.08.018","article-title":"Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation","volume":"104","author":"Baldo","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20092301","article-title":"Complement drives Th17 cell differentiation and triggers autoimmune arthritis","volume":"207","author":"Hashimoto","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-12-063636","article-title":"Regulation of toll-like receptor-mediated inflammatory response by complement in vivo","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.it.2010.01.002","article-title":"Crosstalk pathways between toll-like receptors and the complement system","volume":"31","author":"Hajishengallis","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2014.06.006","article-title":"Cholesterol crystal-induced endothelial cell activation is complement-dependent and mediated by TNF","author":"Nymo","year":"2014","journal-title":"Immunobiology"},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2014.12.305_bb0165","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","article-title":"Therapy for lysosomal storage disorders","volume":"62","author":"Beck","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10545-011-9304-x","article-title":"Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review","volume":"34","author":"van der Linden","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0185","first-page":"101","article-title":"Musculoskeletal health in Hunter disease (MPS II): ERT improves functional outcomes","volume":"3","author":"White","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"MPS VI study group, long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ymgme.2011.08.029","article-title":"Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI","volume":"104","author":"Furujo","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0200","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8weeks of age\u2014a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0205","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/14712598.7.9.1333","article-title":"Gene therapy for mucopolysaccharidosis","volume":"7","author":"Ponder","year":"2007","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0210","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.90.14.6567","article-title":"A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII","volume":"90","author":"Sands","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0162-3109(99)00021-1","article-title":"Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA","volume":"42","author":"Circolo","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ymgme.2014.12.305_bb0220","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: toll-like receptor 4 (Tlr4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for Tlr4 as the Lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/mthe.2002.0527","article-title":"Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs","volume":"5","author":"Xu","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0230","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI114010","article-title":"Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency","volume":"83","author":"Birkenmeier","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0235","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M114.559898","article-title":"Chondroitin sulfate promotes activation of cathepsin K","author":"Lemaire","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.12.305_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2014.07.013","article-title":"Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible","author":"Zhuo","year":"2014","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ymgme.2014.12.305_bb0245","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ymgme.2014.05.015","article-title":"Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I","volume":"112","author":"Wang","year":"2014","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214006982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214006982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:20:59Z","timestamp":1761088859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214006982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1096719214006982"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.12.305","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of Tlr4 and\/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.12.305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}